Health and Social Care Committee

Drugs policy: medicinal cannabis inquiry - publications

Inquiry status: open

Inquiry launched on Thursday 7 December 2018. Report in preparation.

Oral evidence

  • 26 Mar 2019 - Drugs policy: medicinal cannabis - oral evidence | PDF version (PDF301 KB) HC 1821 | Published 01 Apr 2019

    Evidence given by Professor Andrew Goddard, President, Royal College of Physicians, Professor Finbar O'Callaghan, President, British Paediatric Neurology AssociationBaroness Blackwood, Parliamentary Under Secretary of State, Professor Chris Whitty, Chief Scientific Advisor, Department of Health and Social Care, Nick Hurd MP, Minister of State for Policing and the Fire Service, Home Office, Dr Keith Ridge, Chief Pharmaceutical Officer, NHS England

    Watch this evidence session
  • 19 Mar 2019 - Drugs policy: medicinal cannabis - oral evidence | PDF version (PDF374 KB) HC 1821 | Published 21 Mar 2019

    Evidence given by Professor Dame Sally Davies, Chief Medical Officer for England, Alette Addison, Head of Pharmacy Development and Regulation, Department of Health and Social CareGenevieve Edwards, Director of External Affairs, MS Society, Professor Mike Barnes, Interim Chair, Medical Cannabis Clinicians' Society, Peter Carroll, Campaign Director, End Our PainProfessor Helen Cross, Head of Developmental Neurosciences, UCL GOS Institute of Child Health, Dr Imran Malik, Committee member, Royal College of Psychiatrists, Professor Sanjay Sisodiya, Chair of the ABN Epilepsy Advisory Group, Association of British Neurologists

    Watch this evidence session

Written evidence

Receive RSS updates

Share this page